These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1751239)

  • 1. A multicenter study of short hour dialysis using AN69S. Preliminary results.
    Lindsay RM; Spanner E; Heidenheim AP; Burton H; Lindsay S; LeFebvre JM
    ASAIO Trans; 1991; 37(3):M465-7. PubMed ID: 1751239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of dialysis membrane upon protein catabolic rate.
    Lindsay RM; Spanner E; Heidenheim AP; Lindsay S; LeFebvre JM
    ASAIO Trans; 1991; 37(3):M134-5. PubMed ID: 1751080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dialyzers used in shortened dialysis.
    Petersen J; Ramsey KD; Kang MS; Yeh IT
    ASAIO Trans; 1989; 35(3):338-40. PubMed ID: 2688714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocidal effects and residual glutaraldehyde in cellulosic and synthetic polymers.
    Mwaniki DL; Orange G; Courtney JM
    East Afr Med J; 1993 Mar; 70(3):182-5. PubMed ID: 8261949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients].
    García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of cardiopulmonary dysfunction using AN-69 as compared with cellulosic membranes.
    Bogue BA; Butruille Y; Ebert C; Gagneux SA; Strom J
    Proc Clin Dial Transplant Forum; 1977; 7():170-5. PubMed ID: 615995
    [No Abstract]   [Full Text] [Related]  

  • 7. Using AN69 ST membrane: a dialysis centre experience.
    Maheut H; Lacour F
    Nephrol Dial Transplant; 2001 Jul; 16(7):1519-20. PubMed ID: 11427664
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple use of the AN 69 membrane in hemodiafiltration: preliminary clinical experience.
    Canaud B; Nguyen QV; Bonnardet A; Mion C
    Kidney Int Suppl; 1988 Mar; 24():S135-6. PubMed ID: 3163034
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C
    Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production.
    Herbelin A; Ureña P; Man NK; Drüeke T; Descamps-Latscha B
    Contrib Nephrol; 1989; 74():79-85. PubMed ID: 2702150
    [No Abstract]   [Full Text] [Related]  

  • 11. The next generation of dialysis membranes--barriers or pathways?
    Streicher E; Schneider H
    Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient survival on PAN/AN69 membrane hemodialysis: a ten-year analysis.
    Chandran PK; Liggett R; Kirkpatrick B
    J Am Soc Nephrol; 1993 Nov; 4(5):1199-204. PubMed ID: 8305647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous arteriovenous hemofiltration with AN69S membrane; procedures and experience.
    Ronco C; Brendolan A; Bragantini L; Chiaramonte S; Feriani M; Fabris A; Dell'Aquila R; La Greca G; Milan M
    Kidney Int Suppl; 1988 Mar; 24():S150-3. PubMed ID: 3163037
    [No Abstract]   [Full Text] [Related]  

  • 14. Biocompatible membranes in acute renal failure: prospective case-controlled study.
    Shaldon S
    Nephrol Dial Transplant; 1997 Jan; 12(1):235-6. PubMed ID: 9027814
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaphylactic reaction during haemodialysis on AN69 membrane in a patient receiving angiotensin II receptor antagonist.
    Krieter DH; Canaud B
    Nephrol Dial Transplant; 2002 May; 17(5):943-4. PubMed ID: 11981096
    [No Abstract]   [Full Text] [Related]  

  • 16. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
    Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
    Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycentric 384-month study of biofiltration (BF) with AN69s.
    Mioli V; Albertazzi A; Baroni C; Bordoni E; Buoncristiani U; Capponi E; Concetti M; Giombini L; Lombardo V; Ragaiolo M
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():15-6. PubMed ID: 3549572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenge of phagocyte metabolism by extracorporeal circulation and membrane contact. A biocompatibility test.
    Vanholder RC; Dhondt A; Ringoir SM
    ASAIO Trans; 1988; 34(3):543-5. PubMed ID: 3143383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients.
    Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of blood compatibility of haemodialysis membranes using a miniature flat sheet dialyser.
    Mwaniki DL; Courtney JM; Forbes CD; Paul JP
    East Afr Med J; 1992 Mar; 69(3):149-52. PubMed ID: 1505404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.